The Center for Breakthrough Medicines is on track to be the largest single-site cell and gene therapy contract development and manufacturing organization in the world. Our comprehensive service offering accelerates speed to market through supply chain disruption mitigation strategies, end-to-end program management expertise and unique platform technology with the ability to follow a molecule from idea to commercialization. CBM’s integrated approach provides high quality and consistent end-to-end manufacturing capability including: Process and Analytical Development; Plasmid DNA production; Viral Vector Production of Lentivirus; AAV and Adenovirus; Testing and Analytics; Autologous, Allogeneic and Gene-edited Cell Therapy Bioprocessing; and Cell banking. CBM’s horizontal and vertical integration provides one source throughout a product’s life cycle.
CBM’s mission is to accelerate the delivery and affordability of lifesaving and life-changing therapies from discovery to market by offering a complete solution for the development and commercialization of cell and gene therapies.
CBM is located just outside of Philadelphia in the Heart of Cellicon Valley on The Discovery Labs campus set on 300 acres with 2.4 million square feet of life sciences lab and manufacturing space, allowing clients to scale their development and manufacturing needs without ever having to change sites, while providing employees a true community campus experience focused exclusively on life sciences.
The Discovery Labs is a Global Platform Company inclusive of CBM, The Discovery Labs Properties, UniteIQ incubator labs, and The Colony, a unique investment and resource model enabling groundbreaking therapies to be brought to life.
TDL’s Center for Breakthrough Medicines is seeking a highly motivated and independent research scientist to work within the Research and Development. This will encompass a multi-faceted role involved in all aspects of viral manufacturing including upstream/downstream process and analytical development across multiple viruses including, but not limited to Adeno-Associated Virus, Lentivirus, and Adenovirus (AAV, LV, and Ad) in order to build best-in-class viral vector manufacturing technologies. The Scientist will play a key role in establishing viral producer/packaging cell lines, evaluating other manufacturing technologies as well as the development of down-stream processes for the purification and analytical characterization of in process material for all viral vectors. The Scientist role in the Vector Engineering and Manufacturability group at the Center for Breakthrough Medicines offers an exciting opportunity to develop viral purification and analytical strategies for Gene and Cell Therapies to treat many diverse unmet medical needs.
Reports to: Vector Engineering and Manufacturability